Who owns osmotica pharmaceuticals?

Alora is the parent company for three distinct subsidiaries, Avion Pharmaceuticals, LLC, Acella Pharmaceuticals, LLC and Sovereign Pharmaceuticals….

What does osmotica pharmaceutical do?

Osmotica Pharmaceuticals plc is an integrated biopharmaceutical company. The Company is focused on the developing and commercialization of specialty products that target markets with underserved patient populations.

Is osmotica a public company?

Osmotica Pharmaceuticals is listed on the NASDAQ Global Market and traded under the ticker symbol OSMT.

What is Osmodex?

OSMOLEX® ER (amantadine) contains amantadine with an immediate-release outer layer and an extended-release core that is delivered using the Osmodex Drug Delivery System. 1✱ The unique pharmacokinetic profile of OSMOLEX ER delivers amantadine.

Is osmotica pharmaceuticals for sale?

30, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that it has closed the previously announced sale of its legacy business, including certain of the Company’s US subsidiaries dedicated to the legacy business ( …

Is OSMT a good stock to buy?

Osmotica Pharmaceuticals has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Who makes Upneeq?

RVL Pharmaceuticals, Inc.
RVL Pharmaceuticals, Inc. is a new operating subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT), and was created for the purpose of bringing Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% to market.

What is Osmolex used for?

This medication is used to treat Parkinson’s disease. It is also used to treat certain movement disorders caused by some drugs (extrapyramidal reactions). This medication is thought to work by restoring the balance of certain natural substances (neurotransmitters) in the brain.

What is Osmolex?

Osmolex ER, an extended-release formulation of amantadine immediate release, was approved in 2018 by the U.S. Food and Drug Administration (FDA) to treat Parkinson’s motor symptoms (tremor, slowness and stiffness). It works on the dopamine and glutamate brain chemical systems.

Who owns Upneeq?

Osmotica Pharmaceuticals plc

Where is acella located?

Alpharetta, GA
Overview Suggest Edit

Is Upneeq FDA approved?

Upneeq is administered by instilling one drop into one or both ptotic eye(s) once daily….Development Timeline for Upneeq.